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Abstract: Poor vitamin D status has been associated with increased risk and severity of respiratory
tract infections. Whether or not inflammation and infection affects 25-hydroxy vitamin D (25(OH)D)
concentration is controversial and is important in the interpretation of observational studies using
plasma-25(OH)D as a biomarker for status. Our objectives were to measure whether 25(OH)D
concentration was altered by an episode of acute lower respiratory tract infection and whether
markers of inflammation predicted the 25(OH)D concentration. Children aged 2–35 months with
severe (n = 43) and non-severe (n = 387) community-acquired, WHO-defined pneumonia were
included. 25(OH)D concentration and inflammatory markers (cytokines, chemokines, and growth
factors) were measured in plasma during the acute phase and 14, 45, and 90 days later. Predictors
for 25(OH)D concentrations were identified in multiple linear regression models. Mean 25(OH)D
concentration during the acute phase and after recovery (14, 45, and 90 days) was 84.4 nmol/L ± 33.6,
and 80.6 ± 35.4, respectively. None of the inflammatory markers predicted 25(OH)D concentration in
the multiple regression models. Age was the most important predictor for 25(OH)D concentration,
and there were no differences in 25(OH)D concentrations during illness and after 14, 45, and 90 days
when adjusting for age. Infection and inflammation did not alter the 25(OH)D concentration in young
children with acute lower respiratory tract infections.
Keywords: acute lower respiratory tract infection; children; inflammation; vitamin D; Nepal
1. Introduction
Several observational studies have reported an association between vitamin D status and the
incidence and severity of respiratory tract infections in children [1–4]. Despite demonstration of
several immune-modulating effects of vitamin D/vitamin D receptor signaling, such as transcription
of anti-microbial compounds and regulation of cytokine production and immune cell activity [5–9],
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the mechanisms underlying these relationships are still not fully understood. The associations have
also been difficult to reproduce in clinical trials, which is reflected in the heterogeneous results from
recent meta-analyses of this field [10–12]. Additionally, there are examples from studies showing
reduced 25(OH)D concentration during acute episodes of illness/inflammation [13–15], which has
prompted the hypothesis that vitamin D concentration may be affected by inflammation and infection.
Recently, the authors of a systematic review concluded that vitamin D status measured during the
acute phase should be interpreted with care [16], but most of the studies included in this systematic
review were in non-infectious patients, except for one study including 14 adult patients with malaria, in
whom no change in 25(OH)D was found between the acute phase and a follow-up 2–6 weeks later [17].
In another recent study of 30 children aged between nine months and 16 years with bacterial illnesses,
four of whom had pneumonia, no significant difference was found in the 25(OH)D concentration
during the illness compared to after one month [18]. We are not aware of similar studies in younger
children with acute lower respiratory tract infection (ALRI).
Confirmation of the hypothesis of 25(OH)D as a possible negative acute phase reactant in
respiratory tract infections could call for changes in the way we interpret the results and the observed
associations between vitamin D status and illness. In the present study of 430 Nepalese children,
aged 2–35 months, with WHO-defined non-severe and severe pneumonia, we wanted to address this
question further by measuring 25(OH)D concentration during the illness and after recovery and by
identifying predictors of 25(OH)D concentration.
2. Materials and Methods
2.1. Study Population and Study Design
In this study we are using plasma samples from a previously completed randomized, double-blind,
placebo-controlled trial (RCT) in Bhaktapur, Nepal (clinicaltrials.gov: NCT00148733) [19], the primary
objective of which was to measure the clinical effect of zinc supplementation in children with ALRI
(WHO-defined severe and non-severe pneumonia) [20]. A secondary objective was to measure the
vitamin D status in this population. Patients were enrolled from June 2004 to June 2007, and out
of a study sample of 2628, 430 were randomly selected for zinc, vitamin status, and inflammatory
profile analysis. The acute inflammatory profiles in non-severe and severe pneumonia groups have
previously been described in a separate publication [21]. The study population consisted of children
with pneumonia, attending the study clinic at Siddhi Memorial Hospital (in Bhaktapur) because of
cough and/or difficulty breathing. Non-severe pneumonia was diagnosed by the criteria of cough
or breathing difficulties and age-adjusted tachypnea (for children aged 2–11 months defined as
≥50 breaths/min and for children aged ≥12 months defined as ≥40 breaths/min). The presence
of lower chest indrawing (LCI) or other danger signs (such as inability to eat or drink, vomiting,
convulsions, lethargy, or unconsciousness) was used to define severe pneumonia. Children with
wheezing were given two doses of nebulized salbutamol and reassessed after 30 min to see whether he
or she still fulfilled the inclusion criteria. Lack of consent, not planning to live in the area for the next
six months, requiring care for very severe disease, severe malnutrition (defined as being <70% of the
median weight for height according to National Centre for Health Statistics standards), the presence of
congenital heart disease, documented tuberculosis, documentation of any oral antibiotic treatment
in the past 48 h, cough for >14 days, severe anemia (defined as hemoglobin <7 g/dL), and dysentery
were exclusion criteria. Children with severe pneumonia were admitted to the hospital for parenteral
treatment with benzyl penicillin and other supportive treatment. The day of recovery from severe
pneumonia was defined as the beginning of the first 24-h period without LCI, without grunting, and
with no nasal flaring. Antibiotics were then changed to oral amoxicillin for a total of five more days,
and the child would normally be discharged from hospital and monitored daily by a field worker until
recovery from non-severe pneumonia. Children with non-severe pneumonia were treated with oral
cotrimoxazole according to weight twice daily for five days with a daily follow-up of field workers
Nutrients 2017, 9, 52 3 of 11
visiting the child and the parents in their home until recovery. Recovery from non-severe pneumonia
was defined as the first of two consecutive days with a normal respiratory rate.
2.2. Data Collection and Laboratory Procedures
The procedures of collection of socio-demographic and clinical data are also described
elsewhere [19]. All the enrolled children had a capillary or venous blood sample to measure CRP and
hemoglobin instantly. Plasma specimens at baseline were obtained in 430 of the patients, but there
was too little plasma from three of the children to analyze cytokines. End-study blood samples were
taken in 350 children and obtained after 14 days in 182 children, after 45 days in 83 children, and after
90 days in 85 children (Supplementary Materials Figure S1). These time points were selected based
on other predefined outcomes of the study [22]. The specimens were transported on dry ice and kept
frozen at −70 ◦C until analysis. Plasma zinc concentration was determined by inductively coupled
plasma mass spectrometry (PlasmaQuad 3; VG Elemental, Winsford, Cheshire, UK). Hemoglobin
was measured by Hemocue (Hemocue, Vedbæk, Danmark). Cytokine analyses in plasma were
performed at Broegelmanns Research Laboratory, University of Bergen, Norway using magnetic
bead-based multiplex immunoassay for Luminex 100 system (Luminex Corp. Austin, TX, USA)
using the StarSTation v3 (Applied Cytometry Systems, Dinnington, UK) software. The kit used
was the premade “Bio-Plex Pro™ Human Cytokine Standard 27-Plex, Group I-kit” from BioRad
(BioRad Laboratories, Inc. Life Science research, Hercules, CA, USA). Data from the reactions were
acquired using the Luminex reader, while a digital processor managed the data output and the
Luminex software returned data as median fluorescence intensity (MFI) and concentration (pg/ml).
The following cytokines were included in the kit: Interleukin (IL)-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7,
IL-8, IL-9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17A, basic fibroblast growth factor (basic-FGF), eotaxin,
granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage colony-stimulating factor
(GM-CSF), Interferon-gamma (IFN-γ), Interferon-inducing protein-10 (IP-10), MCP-1, macrophage
inflammatory protein 1-alpha (MIP-1α), macrophage inflammatory protein 1-beta (MIP-1β), regulated
on activation, normal T-cell expressed and secreted (RANTES), tumor necrosis factor-alpha (TNF-α),
platelet-derived growth factor subunit B (PDGF-BB), and vascular endothelial growth factor (VEGF).
The serum concentration of the analytes was determined using known standards included in the kits,
and the calculation of 5-parametric standard curves (StarSTation v.3, Applied Cytometry, Dinnington,
UK) [23]. Vitamin D in plasma was analyzed at the Laboratory of Clinical Chemistry, Innlandet
Hospital Trust, Lillehammer, Norway using a Vitamin D total kit from Roche on Cobas. This is a
protein-binding method binding both 25(OH)D2 and 25(OH)D3.
2.3. Statistics
For description of demographic and clinical characteristics, inflammatory markers and vitamin
D status, mean ± SD, median (IQR), or proportions (%) were estimated separately for children with
non-severe and severe pneumonia. Spearman’s correlation was used to estimate correlations between
inflammatory markers and 25(OH)D concentrations. Non-parametric testing was chosen because of
the distribution of the inflammatory markers. A two-sample t-test with equal variances was used for
estimating differences in 25(OH)D concentrations between non-severe and severe pneumonia groups
at baseline and after recovery. We also used generalized additive models (GAM) in the statistical
software R version 3.16 (R Foundation for Statistical Computing, Vienna, Austria) to explore adjusted
nonlinear associations between age or breastfeeding frequency and 25(OH)D concentration [24].
We identified predictors of 25(OH)D concentration in multiple linear regression models using
a step-wise manual selection process [25]. The following candidate variables were included in
this process: age of the child (at the time of blood sampling), gender, z-scores weight for length
as continuous variables, clinical severity based on non-severe/severe groups, CRP, breastfeeding
frequency, mother’s and father’s literacy and occupation, ownership of agricultural land, number of
children, adults, and rooms in the household, indoor tobacco smoke, time until recovery, treatment
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failure, zinc or placebo-treatment, solar radiation, and inflammatory markers. Ownership of land may
be a proxy of socioeconomic status, but was also chosen as a candidate variable because of the possible
impact of agricultural work on sun exposure. We used two different approaches to predict 25(OH)D
concentrations, (1) using only baseline data, i.e., when the children were acutely ill with ALRI; and (2)
using data from both the baseline and the second sample i.e., two samples from each child when he or
she was ill and 14, 45, or 90 days later. In the latter approach, we could compare the concentrations
at baseline and recovery in the same children, taking age into account. In these models, we adjusted
the CI and p values for lack of independence between the two different measurements for each child.
The values of the 27 different cytokines/chemokines and growth factors were log-transformed when
included in the linear models.
To estimate the influence of sunlight on 25(OH)D levels, we used monthly global solar radiation
as given in the article by Adhikari et al. from the Institute of Engineering, Tribhuvan University,
Kathmandu, Nepal. This article provides estimated data for global solar radiation in MJ/m2/day
for the Kathmandu area between 2007 and 2012, using models based on the available parameters
sunshine duration, maximum and minimum temperature, relative humidity, rainfall, and geographical
location [26]. The half-life of 25(OH)D of approximately three weeks will, however, cause a lag for the
effect on vitamin D3 synthesis, so in order to express the association between global solar radiation and
25(OH)D we used the mean of the last three months’ global solar radiation (Supplementary Materials
Figure S2). A p value of 0.05 was considered significant in the final model. Recovery samples were
divided into second sample times of 14, 45, and 90 days.
3. Results
3.1. Child Characteristics
The demographic, clinical characteristics, inflammatory markers, and vitamin D status of the
children are described in Table 1.
Table 1. Baseline characteristics of Nepalese children with community-acquired pneumonia, by severity.
Child Characteristics
Non-Severe Severe
n Value n Value
Demographic data
Age of child (months) mean ± SD 387 14.1 ± 8.5 43 7.7 ± 7.4
Boys n (%) 387 205 (53.0) 43 26 (60.5)
Breastfed—yes n (%) 387 367 (94.8) 43 41 (95.3)
Number of breast feedings past 24 h mean ± SD 387 10.6 ± 5.6 11.4 ± 6.0
Family ownership of land n (%) 387 185 (47.8) 43 20 (46.5)
Living in nuclear family (*) n (%) 387 188 (48.6) 43 24 (55.8)
Number of family members mean ± SD 387 6.2 ± 3.3 43 5.5 ± 3.0
Indoor smoking n (%) 386 248 (64.2) 42 22 (52.4)
Z-score weights for age mean ± SD 387 −0.8 ± 1.1 43 −0.8 ± 1.3
Z-score length/height for age mean ± SD 387 −1.1 ± 1.2 43 −0.7 ± 1.5
Z-score weight for length/height mean ± SD 386 −0.3 ± 1.0 43 −0.5 ± 1.1
Clinical characteristics
Axillary temperature (◦C) mean ± SD 387 37.3 ± 0.9 43 37.3 ± 0.7
Duration of cough (days) mean ± SD 387 3.2 ± 2.0 43 3.1 ± 1.8
Duration of difficulty breathing (days) mean ± SD 387 1.7 ± 1.9 43 1.8 ± 1.5
Duration of fever (days) median (IQR) 387 2 (1–3) 43 2 (1–3)
Respiratory rate/min mean ± SD 387 53 ± 6.7 43 66.0 ± 9.2
Presence of lower chest indrawing (LCI) n (%) 387 0 (0.0) 43 42 (97.7)
SpO2 (%) median (IQR) 387 93.5 (91.5–96.5) 43 91.5 (90.5–95.0)
Hypoxia (SpO2 < 90%) n (%) 387 3 (0.8) 43 9 (20.9)
Time until recovery (days) (**) median (IQR) 387 3 (2–5) 43 6 (4–8)
CRP (mg/L) median (IQR) 387 12 (0–26) 43 25 (0–50)
CRP > 40 (mg/L) n (%) 387 48 (12.4) 43 14 (32.6)
Hemoglobin (g/dL) mean ± SD 387 11.2 ± 1.3 43 10.7 ± 1.5
Vitamin D status
Plasma-25(OH)D (nmol/L) mean ± SD 373 83.4 ± 34.7 40 85.6 ± 32.1
Plasma-25(OH)D < 30 (nmol/L) n (%) 373 20 (5.4) 40 1 (2.5)
Plasma-25(OH)D 30–49 (nmol/L) n (%) 373 42 (11.3) 40 1 (2.5)
Plasma-25(OH)D ≥ 50 (nmol/L) n (%) 373 312 (83.6) 40 39 (97.5)
* Nuclear family = children living together with their parents. ** Time until recovery from non-severe pneumonia.
Demographic and clinical data previously published in: doi:10.1371/journal.pone.0138978.
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3.2. Concentrations and Correlations of 25(OH)D and Inflammatory Markers
Of the 412 children with reliable 25(OH)D concentrations, 85.2% were vitamin D sufficient
(25(OH)D ≥ 50 nmol/L), 10.4% were insufficient (30–49 nmol/L), and 4.4% were deficient (<30 nmol/L)
(Table 1). The concentrations of the inflammatory markers IL-1β, IL-ra, IL-6, IL-8, IL-10, G-CSF, IP-10,
and VEGF were higher at baseline than at recovery (Supplementary Materials Figure S3). Plasma
concentrations of 25(OH)D were slightly higher at baseline compared to after recovery (14, 45, and
90 days after the acute episode), with mean concentrations of 84.4 and 80.6 nmol/L, respectively
(Table 2).
Table 2. Mean 25(OH)D concentration during pneumonia and after recovery in Nepalese children.
During Pneumonia After Recovery
n Mean (*) SD n Mean (*) SD
All children regardless of time for 2nd sample 412 84.4 33.6 343 80.6 35.4
Children with 2nd sample after 14 days 196 82.9 32.9 180 80.0 32.5
Children with 2nd sample after 45 days 102 96.7 35.8 82 90.8 33.3
Children with 2nd sample after 90 days 114 76.1 29.7 81 71.6 38.4
* 25(OH)D in nmol/L.
There were also weak positive correlations between vitamin D concentration and IL-6, IL-15,
eotaxin, and GM-CSF in the baseline samples and weak positive correlations for CRP, IL-4, IL-6, IL-9,
IL-15, eotaxin, G-CSF, GM-CSF, and IP-10 in the recovery samples (Table 3).
Table 3. Spearman’s correlations between vitamin D concentration and demographic data, clinical
characteristics, and inflammatory markers by baseline and after recovery.
Inflammatory Markers
Baseline (VITD1)
(n = 407 or 408)
After Recovery (*) (VITD2)
(n = 338 or 339)
rs p rs p
CRP 0.035 0.484 0.202 <0.001
IL-1β 0.095 0.056 0.017 0.753
IL-1ra 0.011 0.824 0.061 0.265
IL-4 0.062 0.213 0.111 0.041
IL-6 0.133 0.007 0.160 0.003
IL-8 −0.040 0.424 0.006 0.912
IL-9 0.085 0.087 0.213 <0.001
IL-10 −0.043 0.382 0.027 0.622
IL-15 0.209 <0.001 0.222 <0.001
eotaxin 0.124 0.013 0.121 0.027
Basic-FGF 0.020 0.690 0.080 0.141
G-CSF 0.070 0.156 0.123 0.024
GM-CSF 0.161 0.001 0.205 <0.001
TNF-α −0.033 0.504 0.058 0.284
IP-10 −0.046 0.357 0.122 0.025
VEGF 0.018 0.715 0.035 0.523
Continuous demographic and lab data and inflammatory markers showing significant elevation in baseline
samples compared to recovery sample and/or significant differences between groups of clinical severity at
baseline were run in a Spearman’s rank correlation. (rs 0.1–0.29 = weak correlation, rs 030–0.50 = moderate
correlation, rs > 0.50 = strong correlation); * Samples taken after 14, 45, or 90 days.
The 25(OH)D concentration was similar in the non-severe and severe groups both at baseline
(83.4 ± 34.7 vs. 85.5 ± 32.1) and at recovery (80.6 ± 35.4 vs. 80.7 ± 27.0), respectively (Figure 1).
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Figure 1. 25(OH)D concentration for non-severe and severe pneumonia at enrollment and after recovery.
Differences in means are estimated by two-sample t-test with equal variances.
3.3. Predictors of 25(OH)D Concentration
The variables age, breastfeeding frequency, and ownership of land were positively associated
with 25(OH)D concentration at baseline and explained 26% of its variability (Table 4 and Figure 2).
Table 4. Multiple regression model with predictors for plasma 25(OH)D concentrations in Nepalese
children with community-acquired pneumonia.
25(OH)D during Pneumonia
Crude (n = 412) Adjusted (n = 411)
Coeff 95% CI p Coeff 95% CI p Beta
Age in months −1.9 −2.2, −1.6 <0. 1 −1.5 −1.9, −1.1 <0.001 −0.4
No. of breast feedings last 24 h 2.3 1.8, 2.8 <0.001 1.1 0.5, 1.7 <0.001 0.2
Ownership of agricultural land (*) −7.4 −13.9, −0.9 0.025 −7.6 −12.5−1.3 0.016 −0.1
Sex, z-scores weight for length, clinical severity based on non-severe/severe groups, CRP, mother’s and father’s
literacy and occupation, number of children/adults/rooms in the household, indoor tobacco smoke, time until
recovery, treatment failure, zinc or placebo treatment, solar rad ation, and inflamma ory markers w re not
significantly associated with 25(OH)D concentration. Adjusted R-squared = 0.26. Beta: standardized regression
coefficient. * Coded yes = 1, no = 2.
Age was the only variable associated with 25(OH)D concentration in the recovery samples
when analyzing these data separately (Supplementary Materials Table S1). Relevant variables that
were not associated in the multiple regression models were gender, weight for length z-score, solar
radiation, severity of pneumonia, treatment with zinc or placebo, socioeconomic variables like number
of children/adults/rooms in the household, and indoor tobacco smoking. None of the inflammatory
markers were associated with 25(OH)D concentration in the multiple regression models. Age and
ownership of agricultural land could explain 24% of the variability in the model including both 1st
and 2nd sa ple (Table 5).
The 25(OH)D concentration was significantly different from the baseline 14 and 90 days after
the pneumonia episode, but these differences were substantially attenuated and became insignificant
when adjusting for age.
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concentration  in  nmol/L  according  to  age  and  breastfeeding  frequency  by  baseline;  vitamin  D 
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Figure 2. Vitamin D concentration according to age and breastfeeding frequency. Vitamin D
concentration in nmol/L according to age and breastfeeding frequency by baseline; vitamin D
concentration centered around its mean. The graphs showed a similar picture for recovery samples.
Table 5. Multiple regression model of predictors for plasma 25(OH)D concentrations in Nepalese
children during and after recovery from community-acquired pneumonia.
25(OH)D
Crude Adjusted
Coeff 95% CI p Coeff 95% CI p Beta
Baseline plasma sample (ref)
14 days plasma sample −4.7 −8.8, −0.6 0.026 −3.0 −6.7, 0.7 0.117 −0.0
45 days plasma sample 6.1 −0.7, 12.8 0.077 2.3 −3.9, 8.5 0.4 9 .
90 days plasma sample −12.6 −21.7, −3.5 0.007 −2.1 −10.4, 6.1 0.615 −0.0
Age in months −1.9 −2.2, −1.6 <0.001 −1.9 −2.2, −1.6 <0.001 −0.5
Ownership of agricultural land −6.0 −12.0, 0.6 0.076 −5.8 −11.6, −0.0 0.048 −0.1
25(OH)D in first and second samples: Number of obs = 751 Adjusted R-squared = 0.24 Adjusted for repeated
measurements in each child. Beta: standardized regression coefficient. Sex, z-scores weight for length, clinical
severity based on on-severe/sever gr ups, CRP, mother’s and father’s literacy and occup ion, number
of children/adults/rooms in the household, indoor tobacco smoke, time until recovery, treatment failure,
zinc or placebo treatment, solar radiation, and inflammatory markers were not significantly associated with
25(OH)D concentration.
4. Discussion
To elucidate if plasma-25(OH)D changes during infection or by inflammation, we measured
25(OH)D concentration and inflammatory markers during acute illness and after recovery in
children with non-severe and severe pneumonia. We also explored the associations between clinical
and inflammatory markers and plasma 25(OH)D concentration. There were no differences in
plasma-25(OH)D between the groups of non-severe and severe pneumonia either during or after
infection, and there were no differences betwee baseline and recovery 25(OH)D when adjusting for
age. Age of the child, ownership of agric ltur l land in the family, and breastf eding frequency were
significant predictors f 25(OH)D concentration, while the severity of infecti fl atory
markers were not.
In our st dy we observ d a slightly increased 25(OH)D concentration d ri t te hase
compared to after recovery in the crude analysis. s expected, the acute phase was characterized
by a significant increase in the concentration of several inflammatory markers. However, there were
positive correlations between the inflammatory markers and 25(OH)D concentration both at baseline
and after recovery, and there was no difference in the 25(OH)D concentration between non-severe and
severe pneumonia cases, which is contrary to the hypothesis of 25(OH)D as a negative acute phase
reactant. Vitamin D/vitamin D receptor (VDR) signaling is involved in several immune modulating
actions of adaptive and innate immune cells [6–9]. The weak positive correlations between vitamin
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D concentration and some of the inflammatory markers were not significant in the multiple models,
however, and are therefore difficult to interpret. When adjusting for age there also was no significant
difference between plasma-25(OH)D measured during pneumonia and after recovery. The finding
of similar 25(OH)D concentrations in baseline and recovery samples is consistent with the study
of 30 children with bacterial infections [18], where no differences was found during acute illness
compared to four weeks after the infection.
Age was the main predictor for vitamin D status and was negatively associated with the 25(OH)D
concentration, both for the baseline and recovery samples, and could explain the slight decrease in
25(OH)D concentration from enrollment to recovery since all the children were up to three months
older when the second sample was taken. There could be several explanations for this age effect.
There is no current recommendation of vitamin D supplementation for infants in Nepal and the use
of supplements and infant formulas is uncommon [27]. However, data on the use of infant formulas
and other supplements are lacking, and infant formula as a possible contributor to the higher levels in
the youngest children cannot be ruled out. In Bhaktapur there is also a local tradition of giving oil
massages to the naked infant while sunbathing, and outdoor breastfeeding habits have previously
been discussed as a possible reason for replete vitamin D status in young Nepalese children [28].
An interesting finding in our study was that breastfeeding frequency at baseline was positively
associated with plasma-25(OH)D, which could, in part, reflect these sunbathing habits. Recent studies
also suggest that breast milk is adequate in vitamin D when the mother has sufficient circulating
concentrations of vitamin D2 and/or vitamin D3 [29–31], and the vitamin D3 content of the breast
milk is also reported to increase many times compared to 25(OH)D3 in the mother’s serum after
sun exposure [32]. The positive association with breastfeeding frequency could therefore be due to
direct production in the child’s skin during outdoor breastfeeding and oil massage and/or maternal
transfer of vitamin D metabolites through the breast milk. The positive association with ownership
of agricultural land could also fit into this picture, with a possibility of more sun exposure for both
mother and child in agricultural families.
There are some limitations to the study. Pre-infection vitamin D status would have been better
than post-infection samples, but would have required another study design and a larger number of
participants. Inclusion of children with more severe disease, measuring other inflammatory markers,
would maybe have yielded other results. With only 43 patients admitted to hospital for intravenous
antibiotic treatment and other supportive therapy, significant hemodilution seems unlikely at baseline,
but significant dehydration could also mask a lower plasma-25(OH)D by baseline. We would need
more complete data on hydration status to further elucidate its possible role. Finally, similar to most
commercial methods for measuring 25(OH)D concentration, including commercial HPLC-MS/MS,
the kit used in this study did not separate the C3-epimeric forms of 25(OH)D [33]. An overestimation
of 25(OH)D, especially in infants, can therefore not be excluded [34]. Although the importance of C3
epimers is still not fully elucidated, the presence in infants has been reported to amount for 6%–60% of
the vitamin D status [35], and should be acknowledged in further studies. The strengths of the study
are the large population size and the well-characterized illness, both clinically and biochemically.
5. Conclusions
In conclusion, our findings indicate that we do not need to take inflammation or infection into
account when interpreting the concentration of plasma-25(OH)D. Age was the strongest predictor
of vitamin D status, and differences in age explained the slight difference in 25(OH)D concentration
between baseline and recovery.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/9/1/52/s1,
Table S1: Multiple regression model with predictors for plasma 25(OH)D concentrations in Nepalese children after
recovery from community-acquired pneumonia, Figure S1:The patient flow in the study. Out of the 2628 patients,
430 were randomly selected to measure plasma cytokines and 25(OH)D, Figure S2: Estimated average global
solar radiation for current and previous two–four months. Dotted line: Global solar radiation for the last month.
Dashed line: Mean global solar radiation for the two last months. Black solid line: Mean global solar radiation for
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the three last months. Grey solid line: Mean global solar radiation for the four last months, Figure S3: Differences
in concentrations of inflammatory markers during pneumonia (1) and after recover (2). 25(OH)D-concentration
by baseline (1) and after recovery (2). Differences in means are calculated by using rank sum.
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